ClinicalTrials.Veeva

Menu

The Effect of Vitamin B3 on Substrate Metabolism, Insulin Sensitivity, and Body Composition in Obese Men

A

Aarhus University Hospital

Status

Completed

Conditions

Obese

Treatments

Dietary Supplement: Placebo
Dietary Supplement: Nicotinamide riboside (NIAGEN TM, ChromaDex, CA, USA )

Study type

Interventional

Funder types

Other

Identifiers

Details and patient eligibility

About

In animals, treatment with vitamin B3 improved insulin sensitivity and substrate metabolism. It is currently not know if vitamin B3 has the same positive effects in humans. In the current study the effect of a 3 month treatment with vitamin B3 on insulin sensitivity and substrate metabolism in obese men will be investigated.

Enrollment

40 patients

Sex

Male

Ages

40 to 70 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • written signed consent
  • male
  • BMI>30 kg/(m2)
  • age: 40-70
  • no medication
  • non-smoker

Exclusion criteria

  • endocrine disease
  • other severe disease
  • high daily activity level (>30 min / day)

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Quadruple Blind

40 participants in 2 patient groups, including a placebo group

Placebo
Placebo Comparator group
Description:
lime tablets
Treatment:
Dietary Supplement: Placebo
Nicotinamide riboside (NR, Vit B3)
Experimental group
Description:
NIAGEN (ChromaDex) 1 g x 2 orally per day
Treatment:
Dietary Supplement: Nicotinamide riboside (NIAGEN TM, ChromaDex, CA, USA )

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems